Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
True Leaf Pet is a pet wellness company focused on science-backed, plant-based supplements and care products for companion animals, primarily dogs and cats. The business markets veterinary-formulated products across categories including calming support, hip and joint support, functional oils, oral care, topical care, and cat-specific supplements. The current operating entity is Trueleaf Petcare, which states that the original True Leaf Pet brand was founded in 2015, sold in 2020, and relaunched under founder Darcy Bomford and a new team in January 2023. The company emphasizes natural ingredients, human-grade inputs, and veterinary oversight rather than prescription therapeutics or a drug-development pipeline. Its commercial footprint appears focused on North America, with products sold directly online and through retail distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on True Leaf Pet.